|
HCPC 16th Annual National
Symposium on Patient Compliance
May 13-14, 2008
Hyatt Regency
New Brunswick, NJ
|
| Monday, May 12, 2008 |
| 6:00-8:00 pm |
Welcome Reception
|
Sponsored by: Sharp |
| Tuesday, May 13, 2008 |
| 8:00-9:00 am |
Breakfast |
Sponsored by:
MeadWestvaco Healthcare |
| 9:00-9:15 |
Welcoming Remarks |
Chairman, HCPC |
| 9:15-10:00 |
Topic:
MD
Anderson
Study on Packaging and Adherence
Speaker/Title: Carol Looney, MS, Program Manager, Houston CERT,
The
University
of
Texas
, MD
Anderson
Cancer
Center
Abstract:
The
MD Anderson Cancer Center in
Houston
,
Texas
, is home to one of the 14 "Center for Education and Research on
Therapeutics" (CERTs) funded by the Agency for Healthcare Research
and Quality. The CERTs program is a national initiative mandated by
Congress to improve the safety and effectiveness of therapeutics—drugs,
medical devices, and biological products. The Houston CERT is dedicated to
research on health communication, medical decision-making and therapeutic
adherence. In this presentation, Ms. Looney has been asked to outline a
research study that seeks to measure the impact that compliance-prompting
packaging can have on adherence to pharmaceutical regimens. |
| 10:00-10:45 |
Topic: “Pharmaceutical Patient Adherence
and Disease Management: Program
Development, Management and Improvement”
Speaker/Title: Amanda Zunig, Researcher, Cutting Edge
Information (Invited)
Abstract: As the pharmaceutical industry faces
diminishing pipelines, increasingly aggressive generic competition, and a
faltering public image, companies should reexamine their business
practices to maximize the potential of existing patients.
In this presentation, Ms. Zunig will outline the role that improved
compliance with pharmaceutical regimens can have on the profitability of
Rx manufacturers. |
| 10:45-11:15 |
Morning Break |
Sponsored by: Reynolds
Flexible Packaging |
| 11:15-12:00 |
Topic:
Patients, Paradigm Shifts, and Passion for the Job
Speaker/Title:
Dr. Keith Allan, Head of Global Advocacy, Novartis Pharma AG (Invited)
Abstract:
Dr.
Allan recognizes that the business model that has been used by the
pharmaceutical manufacturing industry for decades is now in flux.
Rx manufacturers can no longer focus their marketing efforts
primarily on physicians and, instead, must reach out to patients and
third-party payers as well as doctors if they intend to be successful.
In this presentation, Dr. Allan has been asked to present his views
on this major paradigm shift, and outline some of the steps that Novartis
is taking to adapt to the changing economic forces under which the entire
pharmaceutical manufacturing industry is operating.
|
| 12:00-1:30 |
Lunch/Presentation of the HCPC's
2007 Compliance
Package of the Year Awards |
Sponsored by: One
World Manufacturing and Design Group, Catalent, and Alyward |
| 1:30-2:15 |
Topic: Pharmaceutical Markets
and Marketing from an Outsider's Perspective
Speaker/Title: Ed Silverman, Pharmalot
Abstract: Mr. Silverman edits the widely respected
blog known as "Pharmalot" that is owned by the New Jersey Star
Ledger newspaper. In this role, Mr. Silverman has gained a broad
perspective of the pharmaceutical manufacturing industry as well as the
challenges and opportunities which face that industry. In this
presentation, Mr. Silverman will provide some of his insights on current
and future trends in pharmaceutical markets and marketing. |
| 2:15-3:00 |
Topic:
TBA
Speaker/Title:
Abstract: |
| 3:00-3:30 |
Afternoon Break |
Sponsored by: IMA
North America |
| 3:30-4:15 |
Panel
Session: A Discussion of Current and Future Issues Related to
Pharmaceutical Packaging
Panelists: To Be Announced
Moderator:
Peter
G. Mayberry, Executive Director, Healthcare Compliance Packaging Council |
| 4:15-4:30 |
Closing Remarks/Preview of May 14
Program
Walter Berghahn, AmerisourceBergen Packaging Group, Member of the HCPC
Board of Directors & HCPC Technical Chair |
| 4:30-6:00 |
Reception/Tabletop Displays
Reception Sponsored By: AmerisourceBergen
Packaging Group |
| Wednesday, May 14, 2008 |
| 8:00-9:00 am |
Breakfast |
Sponsored by: Uhlmann
Packaging Systems & Uhlmann VisioTec |
| 9:00-9:15 am |
Welcoming Remarks |
Peter G. Mayberry, HCPC
Executive Director |
| 9:15-9:45 |
Topic: Pfizer’s Perspective on Track and
Trace Efforts in the
US
and Abroad
Speaker/Title: Tim Marsh, Senior Manager, Pfizer
Abstract: In his work
as a technology specialist with Pfizer, Tim Marsh has gained first-hand
insights into anti-counterfeiting and patient safety efforts globally. Tim
will present a manufacturer’s understanding of the pharmaceutical
industry’s traceability requirements to assist providers and end users
of technology to implement successfully. Tim will focus on the Pfizer
approach for the
US
to illustrate how it’s important to balance regional needs with those of
the global environment. |
| 9:45-10:15 |
Topic:
An Overview of GS1’s
Approach to Track and Trace Issues
Speaker/Title:
Dennis Harrison, Senior Vice President, Operations and Planning,
GS1 (Invited)
Abstract:
As an organization, GS1 oversees the most widely-use supply chain
management standards in the world. In
this presentation, Mr. Harrison will address efforts to prevent the
counterfeiting of Rx drugs through better supply chain management. |
| 10:15
- 10:45 |
Morning
Break |
Sponsored
by: Bilcare Research |
| 10:45
– 11:15 |
Topic: HDMA Leadership on Track - and - Trace Technology
in the Healthcare Supply Chain
Speaker Name/Title: Perry Fri, Senior Vice President, Industry
relations, HDMA
Abstract: The
U.S.
healthcare supply chain is one of the most sophisticated in the
world, providing a strong system for the safe and efficient
delivery of medicines to patients nationwide.
Manufacturers, distributors and pharmacies share a responsibility to
continuously monitor, protect and enhance this secure system against
increasingly sophisticated criminals who may try to introduce
counterfeit or diverted drugs into the legitimate chain.
Currently, HDMA is leading efforts to explore technologies that
can track and trace individual units of medication from the manufacturing
plant, to the distributor, to the healthcare provider. These technologies
hold the most promise for safety advances in the supply chain, increased
efficiencies and overall streamlined operations. In this session, Mr. Fri
will discuss HDMA's leadership efforts to develop innovative new research,
industry guidance and public policies that can help supply chain partners
implement current and emerging track-and-trace technologies, such as RFID. |
| 11:15-11:45 |
Panel Discussion:
Global Trends in Pharmaceutical Track and Trace
Moderator:
Walter Berghahn
Panelists:
Tim Marsh
Dennis Harrison
Perry Fri |
| 11:45-12:00 |
Closing Remarks/Adjourn
Hubert Keil, Vice Chairman, HCPC |
|
